PL3986500T3 - Usuwanie komórek nowotworowych z pobranej śródoperacyjnie krwi autologicznej z odzysku z zastosowaniem trójfunkcyjnego przeciwciała - Google Patents

Usuwanie komórek nowotworowych z pobranej śródoperacyjnie krwi autologicznej z odzysku z zastosowaniem trójfunkcyjnego przeciwciała

Info

Publication number
PL3986500T3
PL3986500T3 PL20740338.7T PL20740338T PL3986500T3 PL 3986500 T3 PL3986500 T3 PL 3986500T3 PL 20740338 T PL20740338 T PL 20740338T PL 3986500 T3 PL3986500 T3 PL 3986500T3
Authority
PL
Poland
Prior art keywords
removal
tumor cells
autologous blood
trifunctional antibody
blood salvage
Prior art date
Application number
PL20740338.7T
Other languages
English (en)
Inventor
Horst Lindhofer
Original Assignee
Lindis Blood Care Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lindis Blood Care Gmbh filed Critical Lindis Blood Care Gmbh
Publication of PL3986500T3 publication Critical patent/PL3986500T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3687—Chemical treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/02—Blood transfusion apparatus
    • A61M1/0259—Apparatus for treatment of blood or blood constituents not otherwise provided for
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3615—Cleaning blood contaminated by local chemotherapy of a body part temporarily isolated from the blood circuit
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3692—Washing or rinsing blood or blood constituents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/38—Removing constituents from donor blood and storing or returning remainder to body, e.g. for transfusion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/0021—Special media to be introduced, removed or treated removed from and reintroduced into the body, e.g. after treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0413—Blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0413—Blood
    • A61M2202/0439—White blood cells; Leucocytes

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • External Artificial Organs (AREA)
PL20740338.7T 2019-07-18 2020-07-20 Usuwanie komórek nowotworowych z pobranej śródoperacyjnie krwi autologicznej z odzysku z zastosowaniem trójfunkcyjnego przeciwciała PL3986500T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19186959 2019-07-18
PCT/EP2020/070459 WO2021009383A1 (en) 2019-07-18 2020-07-20 Removal of tumor cells from intraoperative autologous blood salvage by using a trifunctional antibody

Publications (1)

Publication Number Publication Date
PL3986500T3 true PL3986500T3 (pl) 2025-06-23

Family

ID=67437964

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20740338.7T PL3986500T3 (pl) 2019-07-18 2020-07-20 Usuwanie komórek nowotworowych z pobranej śródoperacyjnie krwi autologicznej z odzysku z zastosowaniem trójfunkcyjnego przeciwciała

Country Status (11)

Country Link
US (1) US20250262370A1 (pl)
EP (1) EP3986500B1 (pl)
JP (1) JP7793507B2 (pl)
KR (1) KR102974042B1 (pl)
CN (1) CN114364415B (pl)
AU (1) AU2020313377B2 (pl)
BR (1) BR112022000930A2 (pl)
ES (1) ES3029862T3 (pl)
MX (1) MX2022000744A (pl)
PL (1) PL3986500T3 (pl)
WO (1) WO2021009383A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024261013A1 (en) * 2023-06-21 2024-12-26 F. Hoffmann-La Roche Ag Combination therapy with fap-targeted lymphotoxin beta receptor agonists

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1306095A3 (en) * 1992-03-05 2003-06-25 Board Of Regents, The University Of Texas System Methods and compositions for targeting the vasculature of solid tumors
DE4419399C1 (de) 1994-06-03 1995-03-09 Gsf Forschungszentrum Umwelt Verfahren zur Herstellung von heterologen bispezifischen Antikörpern
US8066989B2 (en) * 2004-11-30 2011-11-29 Trion Pharma Gmbh Method of treating tumor growth and metastasis by using trifunctional antibodies to reduce the risk for GvHD in allogeneic antitumor cell therapy
EP2525222A1 (en) * 2011-05-17 2012-11-21 Markus M. Heiss Initial relative lymphocyte count as predictive biomarker
CN102430163A (zh) * 2011-09-02 2012-05-02 四川大学华西医院 一种术中自体血液回收方法
EP2578230A1 (en) * 2011-10-04 2013-04-10 Trion Pharma Gmbh Removal of Tumor Cells from Intraoperative Autologous Blood Salvage
WO2013113615A1 (en) * 2012-02-03 2013-08-08 F. Hoffmann-La Roche Ag Bispecific antibody molecules with antigen-transfected t-cells and their use in medicine

Also Published As

Publication number Publication date
KR20220038396A (ko) 2022-03-28
JP7793507B2 (ja) 2026-01-05
EP3986500B1 (en) 2025-04-30
CN114364415B (zh) 2026-01-09
US20250262370A1 (en) 2025-08-21
JP2022541551A (ja) 2022-09-26
EP3986500A1 (en) 2022-04-27
AU2020313377A1 (en) 2022-02-03
MX2022000744A (es) 2022-04-18
CN114364415A (zh) 2022-04-15
WO2021009383A1 (en) 2021-01-21
BR112022000930A2 (pt) 2022-03-08
KR102974042B1 (ko) 2026-06-05
ES3029862T3 (en) 2025-06-25
AU2020313377B2 (en) 2025-06-26
EP3986500C0 (en) 2025-04-30

Similar Documents

Publication Publication Date Title
EP2903640B8 (en) Removal of tumor cells from intraoperative autologous blood salvage
ZA202005015B (en) Improved activation of secondary cells for carrier aggregation and dual connectivity
SG11201912780YA (en) Method of preparing anode slurry for secondary battery
MX2019000180A (es) Composiciones de células t para la inmunoterapia.
IL258726B (en) Methods for preparing t cells for cellular therapy
ZA202104521B (en) Artificial promiscuous t helper cell epitopes as immune stimulators for synthetic peptide immunogens
SG11201913493RA (en) Method of preparing cathode for secondary battery
EP3240551A4 (en) Methods of treating hematological disorders, solid tumors, or infectious diseases using natural killer cells
MX2022008266A (es) Metodos para el almacenamiento de sangre completa y composiciones de esta.
SG11201912528VA (en) Method of preparing cathode material for secondary battery
PL3920939T3 (pl) Komórki modyfikowane chimerycznym receptorem antygenowym do leczenia nowotworów z ekspresją cldn6
EP3099334A4 (en) An improved fetal hemoglobin for genetic correction of sickle cell disease
EA201890442A1 (ru) Получение фоторецепторов для лечения заболеваний сетчатки
IL291074A (en) Methods for preparing t cells for t cell therapy
SG11202105084VA (en) Methods of dosing engineered t cells for the treatment of b cell malignancies
ZA201707477B (en) Methods for assesing the purity of a mesenchymal stem cells preparation
SG11202113311XA (en) Method of identifying pro-inflammatory dendritic cells
EA201791346A1 (ru) ТВЕРДЫЕ ФОРМЫ, ВКЛЮЧАЮЩИЕ (1E,4E)-2-АМИНО-N,N-ДИПРОПИЛ-8-(4-(ПИРРОЛИДИН-1-КАРБОНИЛ)ФЕНИЛ)-3H-БЕНЗО[b]-АЗЕПИН-4-КАРБОКСАМИД, ИХ КОМПОЗИЦИИ И ИХ ПРИМЕНЕНИЕ
MX2019001257A (es) Celulas renales bioactivas para el tratamiento de enfermedad renal cronica.
PL3792296T3 (pl) Sposób syntezy polieterów
MX2016003248A (es) Metodos de uso de anticuerpos anti-lgr5.
CL2016001745A1 (es) Ácido (s)-3'-metil-abscísico y ésteres del mismo
ZA202107342B (en) Chiauranib for treatment of small cell lung cancer
IL282477A (en) Liposomes with fusion capability for selective imaging of cancer cells
IL293030B2 (en) Stimuli that cause hyperactivity of local dendritic cells for cancer immunotherapy